Five-Year Health Status After Self-expanding Transcatheter or Surgical Aortic Valve Replacement in High-risk Patients With Severe Aortic Stenosis

IMPORTANCE: In the CoreValve High-Risk Trial, patients with severe symptomatic aortic stenosis had similar clinical outcomes with transcatheter aortic valve replacement (TAVR) vs surgical aortic valve replacement (SAVR) over 5 years of follow-up, with mortality rates of more than 50% in both groups....

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Cardiol
Autores principales: Arnold, Suzanne V., Chinnakondepalli, Khaja M., Magnuson, Elizabeth A., Reardon, Michael J., Deeb, G. Michael, Gleason, Thomas, Yakubov, Steven J., Cohen, David J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2020
Materias:
Brief Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527937/
https://ncbi.nlm.nih.gov/pubmed/32997095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.4397
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares